Nature Reviews Molecular Cell Biology, volume 21, issue 7, pages 384-397

Regulation of human telomerase in homeostasis and disease

Roake Caitlin M 1, 2, 3
Artandi Steven E. 1, 2, 3
1
 
Stanford Cancer Institute, Stanford University School of Medicine, Stanford, USA
2
 
Department of Medicine, Stanford University School of Medicine, Stanford, USA
3
 
Department of Biochemistry, Stanford University School of Medicine, Stanford, USA
Publication typeJournal Article
Publication date2020-04-02
Quartile SCImago
Q1
Quartile WOS
Q1
Impact factor112.7
ISSN14710072, 14710080
Molecular Biology
Cell Biology
Abstract
Telomerase is a ribonucleoprotein complex, the catalytic core of which includes the telomerase reverse transcriptase (TERT) and the non-coding human telomerase RNA (hTR), which serves as a template for the addition of telomeric repeats to chromosome ends. Telomerase expression is restricted in humans to certain cell types, and telomerase levels are tightly controlled in normal conditions. Increased levels of telomerase are found in the vast majority of human cancers, and we have recently begun to understand the mechanisms by which cancer cells increase telomerase activity. Conversely, germline mutations in telomerase-relevant genes that decrease telomerase function cause a range of genetic disorders, including dyskeratosis congenita, idiopathic pulmonary fibrosis and bone marrow failure. In this Review, we discuss the transcriptional regulation of human TERT, hTR processing, assembly of the telomerase complex, the cellular localization of telomerase and its recruitment to telomeres, and the regulation of telomerase activity. We also discuss the disease relevance of each of these steps of telomerase biogenesis. Telomere length is maintained by telomerase, which comprises a reverse transcriptase and a template RNA. Telomerase activity is disrupted in several genetic disorders, but is commonly increased in cancer. Recent studies have uncovered many regulatory mechanisms of telomerase and how telomerase upregulation in cancer is achieved.

Citations by journals

1
2
3
4
5
6
7
8
International Journal of Molecular Sciences
International Journal of Molecular Sciences, 8, 4.4%
International Journal of Molecular Sciences
8 publications, 4.4%
Biomedicines
Biomedicines, 5, 2.75%
Biomedicines
5 publications, 2.75%
Cancers
Cancers, 4, 2.2%
Cancers
4 publications, 2.2%
Frontiers in Cell and Developmental Biology
Frontiers in Cell and Developmental Biology, 3, 1.65%
Frontiers in Cell and Developmental Biology
3 publications, 1.65%
Biomolecules
Biomolecules, 3, 1.65%
Biomolecules
3 publications, 1.65%
Cells
Cells, 3, 1.65%
Cells
3 publications, 1.65%
Nature Communications
Nature Communications, 3, 1.65%
Nature Communications
3 publications, 1.65%
Cell Death and Disease
Cell Death and Disease, 3, 1.65%
Cell Death and Disease
3 publications, 1.65%
Molecular Cell
Molecular Cell, 3, 1.65%
Molecular Cell
3 publications, 1.65%
Nucleic Acids Research
Nucleic Acids Research, 3, 1.65%
Nucleic Acids Research
3 publications, 1.65%
Problemy Endokrinologii
Problemy Endokrinologii, 3, 1.65%
Problemy Endokrinologii
3 publications, 1.65%
Scientific Reports
Scientific Reports, 2, 1.1%
Scientific Reports
2 publications, 1.1%
Nature Reviews Genetics
Nature Reviews Genetics, 2, 1.1%
Nature Reviews Genetics
2 publications, 1.1%
Nature
Nature, 2, 1.1%
Nature
2 publications, 1.1%
Mutation Research - Genetic Toxicology and Environmental Mutagenesis
Mutation Research - Genetic Toxicology and Environmental Mutagenesis, 2, 1.1%
Mutation Research - Genetic Toxicology and Environmental Mutagenesis
2 publications, 1.1%
Trends in Genetics
Trends in Genetics, 2, 1.1%
Trends in Genetics
2 publications, 1.1%
Trends in Cell Biology
Trends in Cell Biology, 2, 1.1%
Trends in Cell Biology
2 publications, 1.1%
Trends in Molecular Medicine
Trends in Molecular Medicine, 2, 1.1%
Trends in Molecular Medicine
2 publications, 1.1%
Clinical and Translational Medicine
Clinical and Translational Medicine, 2, 1.1%
Clinical and Translational Medicine
2 publications, 1.1%
Molecular Oncology
Molecular Oncology, 2, 1.1%
Molecular Oncology
2 publications, 1.1%
ChemBioChem
ChemBioChem, 2, 1.1%
ChemBioChem
2 publications, 1.1%
Angewandte Chemie - International Edition
Angewandte Chemie - International Edition, 2, 1.1%
Angewandte Chemie - International Edition
2 publications, 1.1%
Angewandte Chemie
Angewandte Chemie, 2, 1.1%
Angewandte Chemie
2 publications, 1.1%
ACS Omega
ACS Omega, 2, 1.1%
ACS Omega
2 publications, 1.1%
Journal of the American Chemical Society
Journal of the American Chemical Society, 2, 1.1%
Journal of the American Chemical Society
2 publications, 1.1%
Human Molecular Genetics
Human Molecular Genetics, 2, 1.1%
Human Molecular Genetics
2 publications, 1.1%
BMC Cancer
BMC Cancer, 1, 0.55%
BMC Cancer
1 publication, 0.55%
CNS oncology
CNS oncology, 1, 0.55%
CNS oncology
1 publication, 0.55%
International Journal of Oncology
International Journal of Oncology, 1, 0.55%
International Journal of Oncology
1 publication, 0.55%
1
2
3
4
5
6
7
8

Citations by publishers

5
10
15
20
25
30
35
40
Elsevier
Elsevier, 36, 19.78%
Elsevier
36 publications, 19.78%
Multidisciplinary Digital Publishing Institute (MDPI)
Multidisciplinary Digital Publishing Institute (MDPI), 26, 14.29%
Multidisciplinary Digital Publishing Institute (MDPI)
26 publications, 14.29%
Springer Nature
Springer Nature, 25, 13.74%
Springer Nature
25 publications, 13.74%
Wiley
Wiley, 17, 9.34%
Wiley
17 publications, 9.34%
Frontiers Media S.A.
Frontiers Media S.A., 8, 4.4%
Frontiers Media S.A.
8 publications, 4.4%
American Chemical Society (ACS)
American Chemical Society (ACS), 8, 4.4%
American Chemical Society (ACS)
8 publications, 4.4%
Oxford University Press
Oxford University Press, 7, 3.85%
Oxford University Press
7 publications, 3.85%
Taylor & Francis
Taylor & Francis, 4, 2.2%
Taylor & Francis
4 publications, 2.2%
Endocrinology Research Centre
Endocrinology Research Centre, 3, 1.65%
Endocrinology Research Centre
3 publications, 1.65%
Spandidos Publications
Spandidos Publications, 2, 1.1%
Spandidos Publications
2 publications, 1.1%
Wolters Kluwer Health
Wolters Kluwer Health, 2, 1.1%
Wolters Kluwer Health
2 publications, 1.1%
American Association for Cancer Research (AACR)
American Association for Cancer Research (AACR), 2, 1.1%
American Association for Cancer Research (AACR)
2 publications, 1.1%
Future Medicine
Future Medicine, 1, 0.55%
Future Medicine
1 publication, 0.55%
Biophysical Society
Biophysical Society, 1, 0.55%
Biophysical Society
1 publication, 0.55%
American Society for Biochemistry and Molecular Biology
American Society for Biochemistry and Molecular Biology, 1, 0.55%
American Society for Biochemistry and Molecular Biology
1 publication, 0.55%
Canadian Science Publishing
Canadian Science Publishing, 1, 0.55%
Canadian Science Publishing
1 publication, 0.55%
Walter de Gruyter
Walter de Gruyter, 1, 0.55%
Walter de Gruyter
1 publication, 0.55%
Royal Society of Chemistry (RSC)
Royal Society of Chemistry (RSC), 1, 0.55%
Royal Society of Chemistry (RSC)
1 publication, 0.55%
Cambridge University Press
Cambridge University Press, 1, 0.55%
Cambridge University Press
1 publication, 0.55%
EMBO press
EMBO press, 1, 0.55%
EMBO press
1 publication, 0.55%
eLife Sciences Publications
eLife Sciences Publications, 1, 0.55%
eLife Sciences Publications
1 publication, 0.55%
American Society of Hematology
American Society of Hematology, 1, 0.55%
American Society of Hematology
1 publication, 0.55%
Cold Spring Harbor Laboratory
Cold Spring Harbor Laboratory, 1, 0.55%
Cold Spring Harbor Laboratory
1 publication, 0.55%
American Society for Nutrition
American Society for Nutrition, 1, 0.55%
American Society for Nutrition
1 publication, 0.55%
American Association for the Advancement of Science (AAAS)
American Association for the Advancement of Science (AAAS), 1, 0.55%
American Association for the Advancement of Science (AAAS)
1 publication, 0.55%
American Physiological Society
American Physiological Society, 1, 0.55%
American Physiological Society
1 publication, 0.55%
Farmaceutsko Drustvo Srbije, 1, 0.55%
Farmaceutsko Drustvo Srbije
1 publication, 0.55%
Public Library of Science (PLoS)
Public Library of Science (PLoS), 1, 0.55%
Public Library of Science (PLoS)
1 publication, 0.55%
IOS Press
IOS Press, 1, 0.55%
IOS Press
1 publication, 0.55%
5
10
15
20
25
30
35
40
  • We do not take into account publications that without a DOI.
  • Statistics recalculated only for publications connected to researchers, organizations and labs registered on the platform.
  • Statistics recalculated weekly.
Metrics
Share
Cite this
GOST |
Cite this
GOST Copy
Roake C. M. et al. Regulation of human telomerase in homeostasis and disease // Nature Reviews Molecular Cell Biology. 2020. Vol. 21. No. 7. pp. 384-397.
GOST all authors (up to 50) Copy
Roake C. M., Artandi S. E. Regulation of human telomerase in homeostasis and disease // Nature Reviews Molecular Cell Biology. 2020. Vol. 21. No. 7. pp. 384-397.
RIS |
Cite this
RIS Copy
TY - JOUR
DO - 10.1038/s41580-020-0234-z
UR - https://doi.org/10.1038%2Fs41580-020-0234-z
TI - Regulation of human telomerase in homeostasis and disease
T2 - Nature Reviews Molecular Cell Biology
AU - Roake, Caitlin M
AU - Artandi, Steven E.
PY - 2020
DA - 2020/04/02 00:00:00
PB - Springer Nature
SP - 384-397
IS - 7
VL - 21
PMID - 32242127
SN - 1471-0072
SN - 1471-0080
ER -
BibTex |
Cite this
BibTex Copy
@article{2020_Roake,
author = {Caitlin M Roake and Steven E. Artandi},
title = {Regulation of human telomerase in homeostasis and disease},
journal = {Nature Reviews Molecular Cell Biology},
year = {2020},
volume = {21},
publisher = {Springer Nature},
month = {apr},
url = {https://doi.org/10.1038%2Fs41580-020-0234-z},
number = {7},
pages = {384--397},
doi = {10.1038/s41580-020-0234-z}
}
MLA
Cite this
MLA Copy
Roake, Caitlin M., et al. “Regulation of human telomerase in homeostasis and disease.” Nature Reviews Molecular Cell Biology, vol. 21, no. 7, Apr. 2020, pp. 384-397. https://doi.org/10.1038%2Fs41580-020-0234-z.
Found error?